+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anthrax"

From
Biodefense - Global Strategic Business Report - Product Thumbnail Image

Biodefense - Global Strategic Business Report

  • Report
  • March 2025
  • 363 Pages
  • Global
From
Biodefense Global Market Report 2024 - Product Thumbnail Image

Biodefense Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Biodefense - A Global Market Overview - Product Thumbnail Image

Biodefense - A Global Market Overview

  • Report
  • September 2024
  • 255 Pages
  • Global
From
Biodefence Market Report 2023-2033 - Product Thumbnail Image

Biodefence Market Report 2023-2033

  • Report
  • January 2023
  • 197 Pages
  • Global
From
From
From
Biodefense Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Biodefense Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Bacillus anthracis and Anthrax. Edition No. 1 - Product Thumbnail Image

Bacillus anthracis and Anthrax. Edition No. 1

  • Book
  • January 2011
  • 350 Pages
  • 15 Results (Page 1 of 1)
Loading Indicator

Anthrax is a biological agent used in biodefense. It is a highly infectious disease caused by the bacterium Bacillus anthracis. Anthrax is a potential weapon of bioterrorism and can be used to cause mass casualties. It is also used in the development of vaccines and treatments for biodefense. The anthrax market is a rapidly growing sector of the biodefense industry. It is driven by the need for effective vaccines and treatments to protect against the threat of bioterrorism. Companies in the market are developing new technologies and products to address the threat of anthrax. These include vaccines, treatments, diagnostics, and detection systems. Some companies in the anthrax market include Emergent BioSolutions, CSL Limited, Bavarian Nordic, and GlaxoSmithKline. Show Less Read more